Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma

Stefania La Grutta; Rachele Boccardo; Franco Frati; Paola Puccinelli; Giuseppe Di Cara; Patrizia Berto; Stefania La Grutta; Cristoforo Incorvaia; Renato Ariano

Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma

Stefania La Grutta, Rachele Boccardo, Franco Frati, Paola Puccinelli, Giuseppe Di Cara, Patrizia Berto, Stefania La Grutta, Cristoforo Incorvaia, Renato Ariano

Risultato della ricerca: Article › peer review

26 Citazioni (Scopus)

Abstract

The worldwide increased prevalence of allergic diseases, and especially of respiratory allergy, is paralleled by increased health costs. This requires consideration of the cost to efficacy ratio of the available treatment to identify the optimal choice.

Lingua originale	English
pagine (da-a)	254-259
Numero di pagine	6
Rivista	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
Volume	103
Stato di pubblicazione	Published - 2009

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Accesso al documento

OA Link

Fingerprint Entra nei temi di ricerca di 'Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma'. Insieme formano una fingerprint unica.

Cita questo

Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma. / La Grutta, Stefania; Boccardo, Rachele; Frati, Franco; Puccinelli, Paola; Di Cara, Giuseppe; Berto, Patrizia; La Grutta, Stefania; Incorvaia, Cristoforo; Ariano, Renato.

In: ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, Vol. 103, 2009, pag. 254-259.

Risultato della ricerca: Article › peer review

@article{fad02d8962ce48a9aa7ee5d210f7ea75,

title = "Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma",

abstract = "The worldwide increased prevalence of allergic diseases, and especially of respiratory allergy, is paralleled by increased health costs. This requires consideration of the cost to efficacy ratio of the available treatment to identify the optimal choice.",

author = "{La Grutta}, Stefania and Rachele Boccardo and Franco Frati and Paola Puccinelli and {Di Cara}, Giuseppe and Patrizia Berto and {La Grutta}, Stefania and Cristoforo Incorvaia and Renato Ariano",

year = "2009",

language = "English",

volume = "103",

pages = "254--259",

journal = "ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY",

issn = "1081-1206",

}

TY - JOUR

T1 - Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma

AU - La Grutta, Stefania

AU - Boccardo, Rachele

AU - Frati, Franco

AU - Puccinelli, Paola

AU - Di Cara, Giuseppe

AU - Berto, Patrizia

AU - La Grutta, Stefania

AU - Incorvaia, Cristoforo

AU - Ariano, Renato

PY - 2009

Y1 - 2009

N2 - The worldwide increased prevalence of allergic diseases, and especially of respiratory allergy, is paralleled by increased health costs. This requires consideration of the cost to efficacy ratio of the available treatment to identify the optimal choice.

AB - The worldwide increased prevalence of allergic diseases, and especially of respiratory allergy, is paralleled by increased health costs. This requires consideration of the cost to efficacy ratio of the available treatment to identify the optimal choice.

UR - http://hdl.handle.net/10447/102879

M3 - Article

VL - 103

SP - 254

EP - 259

JO - ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

JF - ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

SN - 1081-1206

ER -